PMID: 6538004Feb 1, 1984Paper

Myasthenia gravis: prolonged treatment with steroids

Neurology
A SghirlanzoniF Cornelio

Abstract

We have evaluated chronic corticosteroid treatment in 60 myasthenic patients; 92% were followed for more than 3 years and 82% longer than 4 years. Improvement was noted in 72% of the patients. The best results were seen in those whose symptoms started after the age of 40 years. There was a correlation between the starting dose of prednisone and the rate of improvement. Complete withdrawal of steroids was possible only for 3 patients.

Citations

May 1, 1995·Annals of Neurology·R A LewisR P Lisak
Oct 1, 1990·Journal of Neurology·R MantegazzaP Tonali
Apr 1, 1991·Journal of Neurology·C AntozziF Fiacchino
Mar 1, 1992·Journal of Neurology·A SghirlanzoniF Cornelio
Dec 1, 1985·Italian Journal of Neurological Sciences·A SghirlanzoniL Morandi
Dec 1, 1987·Italian Journal of Neurological Sciences·G ValliG Scarlato
Apr 1, 1988·Italian Journal of Neurological Sciences·R MantegazzaF Cornelio
Sep 14, 2011·Current Treatment Options in Neurology·Hugh J McMillanPeter B Kang
Jan 1, 1991·Neuromuscular Disorders : NMD·J B KuksH J Oosterhuis
Sep 1, 1997·Journal of the Neurological Sciences·M B BrombergJ W Albers
May 22, 2008·Nature Clinical Practice. Neurology·Sivakumar Sathasivam
Feb 21, 2002·La Revue du praticien·Philippe Gajdos
Dec 1, 2007·International Ophthalmology Clinics·Molly E Gilbert, Peter J Savino
Jul 1, 1991·Acta Neurologica Scandinavica·V CosiA Erbetta
Jul 21, 1998·Acta Neurologica Scandinavica·C LindbergA K Lefvert
Nov 8, 2007·Orphanet Journal of Rare Diseases·Vern C Juel, Janice M Massey
May 10, 2011·Neuropsychiatric Disease and Treatment·Renato MantegazzaCarlo Antozzi
May 4, 2012·Clinical Ophthalmology·Shinichi AsamuraNoritaka Isogai
Aug 17, 2011·Therapeutics and Clinical Risk Management·Sivakumar Sathasivam
Aug 6, 2011·Clinical Drug Investigation·Lorenzo Maggi, Renato Mantegazza
Apr 26, 2012·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·S PouwelsF de Vries
Apr 3, 2001·Ophthalmic Plastic and Reconstructive Surgery·E A BradleyR R Waller
May 19, 2009·Expert Opinion on Pharmacotherapy·Jordi Díaz-ManeraIsabel Illa
Oct 30, 2015·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jeffrey T GuptillMatthew N Meriggioli
Jun 19, 2012·The Medical Clinics of North America·Donna Graves, Steven Vernino
Nov 26, 2010·Journal of Neuroimmunology·Jozsef PalZsolt Illes
Apr 21, 2009·Lancet Neurology·Matthew N Meriggioli, Donald B Sanders
Mar 31, 2004·Muscle & Nerve·John C Keesey
Jul 30, 2014·Acta Neurologica Scandinavica·S HoffmannA Meisel
Nov 1, 1994·Survey of Ophthalmology·D A WeinbergT L Vollmer
Jan 1, 1987·Clinical Neurology and Neurosurgery·H J Scherpbier, H J Oosterhuis
Jan 1, 1987·Annals of the New York Academy of Sciences·T R Johns
Jan 1, 1987·Annals of the New York Academy of Sciences·F CornelioC Collarile
Jan 1, 1992·Clinical Oncology : a Journal of the Royal College of Radiologists·C KirkoveJ van de Merckt
Apr 6, 2004·Neurologic Clinics·Tulio E Bertorini
Sep 23, 2016·Journal of the Neurological Sciences·Lauren Gotterer, Yuebing Li
Jan 1, 1991·Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology·G SplendianiC U Casciani
Oct 23, 2018·Neurology. Neuroimmunology and Neuroinflammation·Ikjae LeeGary Cutter
Jul 3, 2020·Neurology·Ikjae LeeUNKNOWN MGTX study group
Apr 23, 2005·The Cochrane Database of Systematic Reviews·C Schneider-GoldR R Hohlfeld

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.